ZVRA news

Latest 2 stories · newest Nov 3, 2026

ZVRA

Zevra Q3 2026 net revenue up 45% to $37.8M

Zevra reported Q3 2026 net revenue of $37.8 million, up 45% from the prior year, with strong commercial performance of MIPLYFFA driving results, and the company highlighted progress in its pipeline.

Earnings Nov 3, 2026 sentiment +0.50 SEC filing ↗

ZVRA

Zevra Q2 2026 Reacts on MIPLYFFA Sales

Zevra Therapeutics reported net revenue of $39.7 million for Q2 2026, driven by a 53% increase largely from MIPLYFFA sales.

Earnings Aug 5, 2026 sentiment 0.00 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same ZVRA feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/ZVRA/newsSTART FREE